Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Thromboembolytic disease

Thrombin Inhibitors Melagatran/Ximelagatran and Dabigatran as Drugs for the Treatment of Thromboembolytic Disease... [Pg.127]

In 2008, dabigatran (BIBR-953) had also been approved by the FDA for use as an anticoagulant for the treatment of thromboembolytic diseases.It is marketed as a double prodrug, dabigatran etexilate. [Pg.127]

One of the most important recent advances in drug development for thromboembolytic disease has been the recent introduction of oral direct factor X (FXa) inhibitors into clinical practice as a new class of anticoagulants. [Pg.129]

Encouraged by these successes in developing orally active therapies for thromboembolytic diseases, research in the area of FXa and thrombin inhibitors remains very active, with very recent examples of the discovery of more orally active compounds. ... [Pg.130]

See other pages where Thromboembolytic disease is mentioned: [Pg.255]    [Pg.190]    [Pg.211]    [Pg.219]    [Pg.275]    [Pg.294]    [Pg.127]    [Pg.129]    [Pg.255]    [Pg.190]    [Pg.211]    [Pg.219]    [Pg.275]    [Pg.294]    [Pg.127]    [Pg.129]   


SEARCH



© 2024 chempedia.info